Clinical Trial Update: Further Study of AFGen1 Clinical Performance

View source ↗

Summary

Completed study evaluating the clinical performance of AFGen1 for atrial fibrillation assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• AFGen1

Snippet

Sponsor: TriVirum, Inc. | Conditions: Atrial Fibrillation, Afib | Status: COMPLETED